Survey of patients who fail screening for mitral valve interventions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather data on the clinical profiles and anatomical characteristics of patients who do not meet the screening criteria for transcatheter mitral valve interventions (TMVI). It will create a prospective multicenter registry that collects baseline demographics, imaging characteristics, and clinical outcomes of these patients. The goal is to better understand the natural history of mitral valve disease in those who are ineligible for TMVI, which could inform future treatment approaches.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subject failed screening for TMVI

Exclusion Criteria:

* Under 18 years of age
* Subject unable or unwilling to give informed consent
* Subject proceeded with TMVI.

Where it's running

• Phoenix Cardiovascular Research Group
  Phoenix, Arizona, United States Recruiting
• Keck Hospital of USC
  Los Angeles, California, United States Recruiting
• MedStar Washington Hospital Center
  Washington D.C., District of Columbia, United States Recruiting
• Morton Plant Hospital
  Clearwater, Florida, United States Recruiting
• HealthPark Medical Center
  Fort Myers, Florida, United States Recruiting
• Northwestern University
  Chicago, Illinois, United States Recruiting

Study contacts

• Study coordinator: Kassandra Lopez
• Email: kassandra.lopez@medstar.net
• Phone: 202-877-2452

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• MRace Implant: A first look at fixing the mitral valve to reduce regurgitation

  This single-arm study tests whether the MRace Implant and Delivery System can safely place a prosthesis to reduce severe mitral regurgitation in high-risk patients who may not be good candidates for open-heart surgery.

  Recruiting at 4 sites Polares Medical SA · Tbilisi and 3 other locations · NCT07796659

• Mitral Valve Calcification Imaging with TrueVue 3D Light Rendering

  This study tests how well three-dimensional transesophageal echocardiography with TrueVue transillumination detects mitral valve calcifications compared with CT in adults.

  Recruiting Centro Cardiologico Monzino · Milan, Milan · NCT07612553

• Tracking progression and consequences of heart valve disease

  This project will follow adults with moderate or worse valve disease to see if clinical tests and imaging can predict when their condition will get worse.

  Recruiting at 15 sites Second Affiliated Hospital, Zhejiang University, School of Medicine · Fuzhou, Fujian and 14 other locations · NCT07267117

• Surgical implantation of a polymer prosthetic mitral or aortic valve

  This will test a surgically implanted polymer heart valve to see if it is safe and works well for adults who need mitral or aortic valve replacement.

  Recruiting Mitrassist Lifesciences Limited Co., Ltd. · Shanghai, Shanghai Municipality · NCT07097740

• Abbott Cephea registry for mitral valve disease

  Collects clinical information on adults with symptomatic mitral valve disease to see how correcting the valve with the Cephea system affects outcomes for patients who might be candidates for transcatheter mitral valve replacement.

  Recruiting at 24 sites Abbott Medical Devices · Birmingham, Alabama and 23 other locations · NCT07069673

• Using the CoolCryo System to treat Atrial Fibrillation during Mitral Valve Surgery

  This study is testing whether the CoolCryo system can safely help people with atrial fibrillation feel better during mitral valve surgery.

  Recruiting at 2 sites Medinice S.A. · Bydgoszcz and 1 other locations · NCT06557616

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.